← All trials
NCT02040441
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2013
- Primary completion
- Dec 1, 2017
- Completion date
- Dec 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 3500
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- University of CopenhagenLead sponsor
- Steno Diabetes Center CopenhagenSponsor investigator
- Steno Diabetes Center CopenhagenStudy chair
- University of GlasgowOverall official - principal investigator
- University of GroningenOverall official - principal investigator
- Institut Universitaire de Recherche Clinique, RD Nephrologie SASOverall official - principal investigator
- Charles UniversityOverall official - principal investigator
- Mario Negri InstituteOverall official - principal investigator
- University of SkopjeOverall official - principal investigator
- University of GlasgowCollaborator
- University of GroningenCollaborator
- Mosaiques Diagnostics GmbHCollaborator
- Geniko Nosokomeio Athinas IppokrateioCollaborator
- European CommissionCollaborator
- Charles UniversityCollaborator
- University of LeipzigCollaborator
- Mario Negri InstituteCollaborator
- Hannover Clinical Trial Center GmbHCollaborator
- Cyril and Methodius UniversityCollaborator
- Geniko Nosokomeio Athinas IppokrateioOverall official - principal investigator
- Universidad Autonoma de MadridOverall official - principal investigator
- Universidad Autonoma de MadridCollaborator
- University of LeipzigOverall official - principal investigator
- University of MontpellierCollaborator
- Humboldt UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.